Thermo Fisher Scientific Anivovetmab Caninized Recombinant Canine Monoclonal Antibody

Applications

Tested Dilution

Publications

ELISA (ELISA)

Assay-dependent

-

Product Specifications

Species Reactivity

Virus

Host/Isotype

Dog / IgG2, kappa

Expression System

CHO cells

Class

Recombinant Monoclonal

Type

Antibody

Immunogen

Recombinant CPV-2 Capsidprotein VP2.

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

0.9 mg/mL

Purification

Protein A/G

Storage buffer

PBS

Contains

no preservative

Storage conditions

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Product Specific Information

Compatible with Direct ELISA

Target Information

Anivovetmab, an anti-VP2 monoclonal antibody, is a biosimilar designed for canine applications, particularly targeting the major capsid protein VP2 of Canine Parvovirus. It is a chimeric monoclonal antibody combining sequences from Canis familiaris and Rattus norvegicus, forming a disulfide-linked dimer. Anivovetmab functions by binding to the VP2 protein, neutralizing the virus, and aiding the immune system in clearing the infection. This biosimilar mimics the IgG structure with gamma and kappa chains typical to the immunoglobulin family, ensuring its efficacy in antiviral defense. The primary application of Anivovetmab is in veterinary medicine for preventing and treating parvovirus infections in dogs.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.